Skip to main content
. 1996 Nov 12;93(23):13152–13157. doi: 10.1073/pnas.93.23.13152

Table 3.

Inhibitory activity of NNRTIs and NRTIs against mutant HIV-1/IIIB strains in CEM cell cultures

Compound Fold increase of EC50 versus wild-type virus
Wild type* 184-Ile 184-Val 188-His 184-Ile + 188-His 184-Val + 188-His
Nevirapine 1  (0.03) 0.67 2.3 1.7 28 6.7
BHAP U-90152 1  (0.006) 1.0 0.50 10 167 83
Pyridinone L-697661 1  (0.017) 0.76 0.41 58 2.9
TSAO-m3T 1  (0.021) 1.2 0.71 71 381 38
9-chloro-TIBO 1  (0.02) 1.0 0.50 45
α-APA 1  (0.005) 2.8 0.80 100 960 70
MKC-442 1  (0.002) 1.0 1.0 390 25
UC-10 1  (0.029) 0.30 0.28 6.9 7.9 2.7
UC-781 1  (0.002) 8.0 37 8.0
HBY 097 1  (0.001) 1.0 3.0 2.0 19 5.0
AZT 1  (0.001) 1.7 1.0 1.3 1.2 1.5
ddI 1  (0.92) 2.8 2.6 0.49 1.3 1.3
3TC 1  (0.01) 70 ≥5,000 0.60 280 >2,000
*

Values in parentheses represent the 50% effective concentration (EC50) values of the drugs for wild-type HIV-1/IIIB (in μg/ml). ddI, dideoxyinosine.